Loading song details...
Onyee Chan MD Phase 1 1b CPX 351 GO Dose Escalation In Newly Diagnosed AML
No description available.
MP3 Download
Video Download
Related Songs
2:46
Onyee Chan MD Phase 1 1b CPX 351 GO Dose Escalation In Newly Diagnosed AML
4:07
Onyee Chan MD Jeffrey Lancet Early AML Combo Therapy ML Advances
1:50
ASH 2024 Onyee Chan MD On Defining Intolerance To Tyrosine Kinase Inhibitor Treatment
3:14
Nelli Bejanyan MD Onyee Chan Allo Transplant Vs HMA Venetoclax In AML 70
1:22
ASH 2024 Onyee Chan MD Presented Phase 1 Study CPX 351 Gemtuzumab In AML Treatment
2:05
Onyee Chan MD VEN HMA Vs IDHi As Frontline Options In IDH Mutated AML
21:57
Managing Toxicities Of Tyrosine Kinase Inhibitors TKI In CML Drs Onyee Chan Fadi Haddad
1:26
ASH 2024 Dr Onyee Chan On Phase 1 Study Of CPX 351 Gilteritinib In FLT3 Mutated AML
1:48
ASH 2021 Dr Onyee Chan Abstract 686
3:18
The Impact Of Secondary AML Mutations On Prognosis Patients With NPM1 Mutated
3:21
The Prognostic Impact Of FLT3 ITD And TKD In NPM1 Mutated AML
0:39
Potential Use Of Machine Learning Methods To Restratify AML Patients 2022 ESMO Florida
0:48
Current And Emerging Methods For Restratifying Acute Myeloid Leukemia Patients 2022 ESMO Florida
0:23
UnityPoint Health Des Moines Pauses Elective Surgeries Amid High Patient Volumes
0